DiscoverTHE MORNING BRIEFSouth Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection
South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection

South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection

Update: 2025-10-29
Share

Description

South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection.

Guest: Prof. Glenda Gray - Director of the Infectious Disease and Oncology Research Institute (IDORI) at Wits University

 

 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection

South Africa has made global headlines by becoming the first country in Africa — and only the third in the world — to approve lenacapavir (LEN), a revolutionary twice-yearly injectable drug that prevents HIV infection

SAfm